The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Open accessAbstract
These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
Self-citationOstrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326
Self-citationWeller, M., van den Bent, M., Tonn, J. C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., Henriksson, R., Rhun, E. L., Balana, C., Chinot, O., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30194-8 · Cited by 1,088
Self-citationImmunotherapy response assessment in neuro-oncology: a report of the RANO working group
Okada, H., Weller, M., Huang, R., Finocchiaro, G., Gilbert, M. R., Wick, W., Ellingson, B. M., Hashimoto, N., Pollack, I. F., Brandes, A. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00088-1 · Cited by 781
Self-citationAlbert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C., Pope, W., Law, I., Arbizu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now058 · Cited by 744
Self-citationPauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F., Någren, K., Darcourt, J., Kapucu, Ö. L., Tatsch, K., Bartenstein, P., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1264-0 · Cited by 544
Clinical Applications of PET in Brain Tumors
Chen, W. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037689 · Cited by 449
Terakawa, Y., Tsuyuguchi, N., Iwai, Y., Yamanaka, K., Higashiyama, S., Takami, T., & Ohata, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048082 · Cited by 419
Mattsson, S., Johansson, L. F., Svegborn, S. L., Liniecki, J., Noßke, D., Riklund, K., Stabin, M. G., Taylor, D. M., Bolch, W. E., Carlsson, S., et al. (2015) · Annals of the ICRP · doi:10.1177/0146645314558019 · Cited by 405
Advances in neuro-oncology imaging
Langen, K.-J., Galldiks, N., Hattingen, E., & Shah, N. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.44 · Cited by 339
Self-citationDelineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Klein, J. C., Herholz, K., & Heiss, W.-D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0262 · Cited by 292
Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Sabel, M., Reifenberger, G., Kebir, S., Dorn, F., Blau, T., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2959-4 · Cited by 266
Self-citationMinoshima, S., Koeppe, R. A., Mintun, M. A., Berger, K. L., Taylor, S. F., Frey, K. A., & Kuhl, D. E. (1993) · PubMed · Cited by 255
Ladefoged, C. N., Law, I., Anazodo, U., St. Lawrence, K., Izquierdo-Garcia, D., Catana, C., Burgos, N., Cardoso, M. J., Ourselin, S., Hutton, B., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.12.010 · Cited by 229
Self-citation11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral Gliomas
Singhal, T., Narayanan, T. K., Jain, V., Mukherjee, J., & Mantil, J. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0115-2 · Cited by 227
Pafundi, D. H., Laack, N. N., Youland, R. S., Parney, I. F., Lowe, V. J., Giannini, C., Kemp, B. J., Grams, M. P., Morris, J. M., Hoover, J. M., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not002 · Cited by 218
Self-citationGalldiks, N., Langen, K.-J., Holy, R., Pinkawa, M., Stoffels, G., Nolte, K. W., Kaiser, H. J., Filss, C. P., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098590 · Cited by 204
Self-citationThe new EANM paediatric dosage card
Committees, F. T. E. D. A. P., Lassmann, M., Biassoni, L., Monsieurs, M., Franzius, C., & Jacobs, F. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0370-0 · Cited by 197
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Rapp, M., Heinzel, A., Galldiks, N., Stoffels, G., Felsberg, J., Ewelt, C., Sabel, M., Steiger, H. J., Reifenberger, G., Beez, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109603 · Cited by 193
Self-citationAndersen, F. L., Ladefoged, C. N., Beyer, T., Keller, S. H., Hansen, A. E., Højgaard, L., Kjær, A., Law, I., & Holm, S. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.042 · Cited by 190
Self-citationDunet, V., Pomoni, A., Hottinger, A., Nicod-Lalonde, M., & Prior, J. O. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov148 · Cited by 183
Galldiks, N., Rapp, M., Stoffels, G., Fink, G. R., Shah, N. J., Coenen, H. H., Sabel, M., & Langen, K.-J. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2251-4 · Cited by 171
Self-citationGalldiks, N., Langen, K.-J., & Pope, W. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov118 · Cited by 170
Self-citationHutterer, M., Nowosielski, M., Putzer, D., Waitz, D., Tinkhauser, G., Kostron, H., Muigg, A., Virgolini, I. J., Staffen, W., Trinka, E., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086645 · Cited by 168
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
Nihashi, T., Dahabreh, I. J., & Terasawa, T. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3324 · Cited by 165
High resolution BrainPET combined with simultaneous MRI
Langen, K., Weirich, C., Kops, E. R., Kaffanke, J. B., Tellmann, L., Scheins, J. J., Neuner, I., Stoffels, G., Fischer, K., Caldeira, L., et al. (2011) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0347-10-09 · Cited by 145
Self-citationvon Schwarzenberg, J., Czernin, J. G., Cloughesy, T. F., Ellingson, B. M., Pope, W. B., Grogan, T., Elashoff, D. A., Geist, C. L., Silverman, D. H. S., Phelps, M. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1440 · Cited by 141
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
Galldiks, N., Kracht, L., Burghaus, L., Thomas, A., Jacobs, A. H., Heiss, W., & Herholz, K. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0002-5 · Cited by 139
Self-citationKebir, S., Fimmers, R., Galldiks, N., Schäfer, N., Mack, F., Schaub, C., Stuplich, M., Nießen, M., Tzaridis, T., Simon, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1334 · Cited by 130
Self-citationRoutine quality control recommendations for nuclear medicine instrumentation
Sokole, E. B., With contribution from the EANM Working Group on Nuclear Medicine Instrumentation Quality Control:, Płachcińska, A., Britten, A. J., Georgosopoulou, M. L., Tindale, W., & Klett, R. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1347-y · Cited by 124
Galldiks, N., Stoffels, G., Ruge, M. I., Rapp, M., Sabel, M., Reifenberger, G., Erdem, Z., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123836 · Cited by 124
Self-citationStatic and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status
Verger, A., Stoffels, G., Bauer, E. K., Lohmann, P., Blau, T., Fink, G. R., Neumaier, B., Shah, N. J., Langen, K., & Galldiks, N. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3846-6 · Cited by 123
Self-citationThe FDG lumped constant in normal human brain.
Graham, M. M., Muzi, M., Spence, A. M., O’Sullivan, F., Lewellen, T. K., Link, J. M., & Krohn, K. A. (2002) · PubMed · Cited by 118
Herrmann, K. A., Czernin, J. G., Cloughesy, T. F., Lai, A., Pomykala, K. L., Benz, M., Buck, A. K., Phelps, M. E., & Chen, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not166 · Cited by 115
Jansen, N. L., Schwartz, C., Graute, V., Eigenbrod, S., Lutz, J., Egensperger, R., Pöpperl, G., Kretzschmar, H. A., Cumming, P. D., Bartenstein, P., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos259 · Cited by 109
Self-citationGalldiks, N., Ullrich, R. T., Schroeter, M., Fink, G. R., & Kracht, L. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1219-5 · Cited by 96
Self-citationFDG-PET as a Prognostic Factor in High-grade Astrocytoma
Witte, O. D., Lefranc, F., Levivier, M., Salmon, I. J., Brotchi, J., & Goldman, S. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1026518002800 · Cited by 94
Koesters, T., Friedman, K. P., Fenchel, M., Zhan, Y., Hermosillo, G., Babb, J. S., Jelescu, I., Faul, D. D., Boada, F. E., & Shepherd, T. M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166967 · Cited by 93
Schiepers, C. W., Hecke, P. V., Vandenberghe, R. R., Oostende, S. V., Dupont, P. J., Demaerel, P., Bormans, G. M., & Carton, H. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300102 · Cited by 92
Suchorska, B., Giese, A., Biczok, A., Unterrainer, M., Weller, M., Drexler, M., Bartenstein, P., Schüller, U., Tonn, J., & Albert, N. L. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox153 · Cited by 92
Self-citationIs there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
Pichler, R., Dunzinger, A., Wurm, G., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1457-6 · Cited by 88
Suggested pathway to assess radiation safety of 18F-labeled PET tracers for first-in-human studies
Zanotti‐Fregonara, P., Lammertsma, A. A., & Innis, R. B. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2512-x · Cited by 87
Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative
Munk, O. L., Tolbod, L. P., Hansen, S. B., & Bogsrud, T. V. (2017) · EJNMMI Physics · doi:10.1186/s40658-016-0169-9 · Cited by 84
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan
Colavolpe, C., Chinot, O. L., Métellus, P., Mancini, J., Barrié, M., Bequet, C., Tabouret, É., MUNDLER, O., Figarella‐Branger, D., & Guedj, É. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos012 · Cited by 81
Zazulia, A. R., Videen, T. O., & Powers, W. J. (2009) · Stroke · doi:10.1161/strokeaha.108.536037 · Cited by 77
Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma.
Dethy, S., Goldman, S., Blecic, S. A., Luxen, A., Levivier, M., & Hildebrand, J. G. (1994) · PubMed · Cited by 61
Tsuyuguchi, N., Sunada, I., Ohata, K., Takami, T., Nishio, A., Hara, M., Kawabe, J., Okamura, T., & Ochi, H. (2003) · Annals of Nuclear Medicine · doi:10.1007/bf02988258 · Cited by 61
F-18 FDG PET-CT in patients with recurrent glioma: Comparison with contrast enhanced MRI
Santra, A., Kumar, R., Sharma, P., Bal, C. S., Kumar, A., Julka, P. K., & Malhotra, A. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.01.080 · Cited by 60
Bailey, D. L., Pichler, B. J., Gückel, B., Antoch, G., Barthel, H., Bhujwalla, Z. M., Biskup, S., Biswal, S., Bitzer, M., Boellaard, R., et al. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1123-5 · Cited by 60
Self-citationSaito, T., Maruyama, T., Muragaki, Y., Tanaka, M., Nitta, M., Shinoda, J., Aki, T., Iseki, H., Kurisu, K., & Okada, Y. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3173 · Cited by 59
Impact of incorrect tissue classification in Dixon-based MR-AC: fat-water tissue inversion
Ladefoged, C. N., Hansen, A. E., Keller, S. H., Holm, S., Law, I. G., Beyer, T., Højgaard, L., Kjær, A., & Andersen, F. L. (2014) · EJNMMI Physics · doi:10.1186/s40658-014-0101-0 · Cited by 51
Self-citationPET findings in a brain abscess associated with a silent atrial septal defect
Dethy, S., Manto, M. U., Kentos, A., Konopnicki, D., Pirotte, B. J. M., Goldman, S., & Hildebrand, J. G. (1995) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(95)00067-t · Cited by 50
Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia
Salber, D., Stoffels, G., Pauleit, D. O., Reifenberger, G., Sabel, M., Shah, N. J., Hamacher, K., Coenen, H. H., & Langen, K. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.09.004 · Cited by 49
Self-citationBrendle, C., Schmidt, H., Örgel, A., Bezrukov, I., Mueller, M., Schraml, C., Pfannenberg, C., la Fougère, C., Nikolaou, K., & Schwenzer, N. F. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000131 · Cited by 46
Amino Acid Uptake in Ischemically Compromised Brain Tissue
Jacobs, A. (1995) · Stroke · doi:10.1161/01.str.26.10.1859 · Cited by 44
Impact of imaging measurements on response assessment in glioblastoma clinical trials
Reardon, D. A., Ballman, K., Buckner, J. C., Chang, S. M., & Ellingson, B. M. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou286 · Cited by 41
Bette, S. J., Gempt, J., Delbridge, C., et al. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.01.085 · Cited by 40
11C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas
Okita, Y., Nonaka, M., Shofuda, T., Kanematsu, D., Yoshioka, E., Kodama, Y., Mano, M., Nakajima, S., & Kanemura, Y. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2014.08.004 · Cited by 36
PET/MRI in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data
Fuin, N., Pedemonte, S., Catalano, O. A., Izquierdo‐Garcia, D., Soricelli, A., Salvatore, M., Heberlein, K., Hooker, J. M., Leemput, K. V., & Catana, C. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183343 · Cited by 32
Ladefoged, C. N., Andersen, F. L., Kjær, A., Højgaard, L., & Law, I. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00453 · Cited by 31
Self-citationPET in the Clinical Management of Glioma: Evidence Map
Nihashi, T., Dahabreh, I. J., & Terasawa, T. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9168 · Cited by 29
ter Voert, E. E. G. W., Veit‐Haibach, P., Ahn, S., Wiesinger, F., Khalighi, M. M., Levin, C. S., Iagaru, A. H., Zaharchuk, G., Huellner, M. W., & Delso, G. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3619-2 · Cited by 27
Ladefoged, C. N., Hansen, A. E., Keller, S. H., Fischer, B. M., Rasmussen, J. H., Law, I. G., Kjær, A., Højgaard, L., Lauze, F., Beyer, T., et al. (2015) · EJNMMI Physics · doi:10.1186/s40658-015-0112-5 · Cited by 25
Self-citation
Cited by
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Self-citationEANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
Guedj, E., Varrone, A., Boellaard, R., Albert, N. L., Barthel, H., van Berckel, B., Brendel, M., Cecchin, D., Ekmekcioglu, O., Garibotto, V., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05603-w · Cited by 300
Self-citationNuclear medicine and molecular imaging advances in the 21st century
Vaz, S. C., Oliveira, F., Herrmann, K., & Veit-Haibach, P. (2020) · The British Journal of Radiology · doi:10.1259/bjr.20200095 · Cited by 86
Metadata
- Authors
- Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., McConathy, J., Quick, H. H., Sattler, B., Schuster, D. M., Tonn, J.-C., & Weller, M.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2018-12-05
- Volume
- 46
- Issue
- 3
- Pages
- 540-557
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2902487187
- Cited by
- 556
- References
- 69
- FWCI
- 31.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.